[
  {
    "date": "2023-12-30",
    "symbol": "VCNX",
    "period": "FY",
    "netincomeloss": -20251000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VCNX",
    "entityregistrantname": "Vaccinex, Inc.",
    "entitycentralindexkey": 1205922,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "001-38624",
    "entitytaxidentificationnumber": "16-1603202",
    "entityaddressaddressline1": "1895 Mount Hope Avenue",
    "entityaddresscityortown": "Rochester",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 14620,
    "cityareacode": 585,
    "localphonenumber": "271-2700",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Rochester, New York",
    "cashandcashequivalentsatcarryingvalue": 1535000,
    "accountsreceivablenetcurrent": 961000,
    "prepaidexpenseandotherassetscurrent": 853000,
    "assetscurrent": 3349000,
    "propertyplantandequipmentnet": 136000,
    "operatingleaserightofuseasset": 146000,
    "assets": 3631000,
    "accountspayablecurrent": 2039000,
    "accruedliabilitiescurrent": 1242000,
    "contractwithcustomerliabilitycurrent": 63000,
    "longtermdebtcurrent": 75000,
    "operatingleaseliabilitycurrent": 146000,
    "derivativeliabilitiescurrent": 2351000,
    "liabilitiescurrent": 5916000,
    "longtermdebtnoncurrent": 26000,
    "liabilities": 5942000,
    "additionalpaidincapitalcommonstock": 337627000,
    "treasurystockvalue": 11000,
    "retainedearningsaccumulateddeficit": -339927000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -2311000,
    "liabilitiesandstockholdersequity": 3631000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 892622,
    "commonstocksharesoutstanding": 892617,
    "treasurystockcommonshares": 5,
    "revenuefromcontractwithcustomerexcludingassessedtax": 570000,
    "researchanddevelopmentexpense": 16574000,
    "generalandadministrativeexpense": 6881000,
    "costsandexpenses": 23455000,
    "operatingincomeloss": -22885000,
    "interestexpense": 1000,
    "financingcostswarrantliabilities": -383000,
    "fairvalueadjustmentofwarrants": 2106000,
    "othernonoperatingincomeexpense": 912000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -20251000,
    "comprehensiveincomenetoftax": -20251000,
    "earningspersharebasic": -43.68,
    "earningspersharediluted": -43.68,
    "weightedaveragenumberofsharesoutstandingbasic": 463653,
    "weightedaveragenumberofdilutedsharesoutstanding": 463653,
    "sharesoutstanding": 892622,
    "issuanceofcommonstockandprefundedwarrantsvalue": 4971000,
    "issuanceofcommonstockandprefundedwarrantsshares": 542857,
    "stockissuedduringperiodvaluenewissues": 6024000,
    "stockissuedduringperiodsharesnewissues": 94087,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 474000,
    "profitloss": -20251000,
    "depreciation": 119000,
    "sharebasedcompensation": 474000,
    "increasedecreaseinaccountsreceivable": 786000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -59000,
    "increasedecreaseinaccountspayable": 521000,
    "increasedecreaseinaccruedliabilities": 461000,
    "increasedecreaseindeferredrevenue": 63000,
    "netcashprovidedbyusedinoperatingactivities": -17234000,
    "paymentstoacquirepropertyplantandequipment": 67000,
    "netcashprovidedbyusedininvestingactivities": -67000,
    "proceedsfromissuanceofcommonstockandprefundedwarrants": 4971000,
    "proceedsfromissuanceofcommonstock": 1278000,
    "proceedsfromissuanceofprivateplacement": 6270000,
    "repaymentsoflongtermdebt": 74000,
    "netcashprovidedbyusedinfinancingactivities": 12445000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -4856000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 1535000,
    "stockholdersequityreversestocksplit": "Company effected a 1-for-15 reverse stock split of its issued shares of common stock. On February 19, 2024, the Company effected a second reverse split of shares of the Company's common stock on a 1-for-14 basis. All per share amounts, common shares outstanding, warrants, and stock-based compensation amounts for all periods presented have been retroactively adjusted to reflect these reverse stock splits.",
    "saleofstocknumberofsharesissuedintransaction": 3409,
    "saleofstockpricepershare": 83.63,
    "saleofstockconsiderationreceivedpertransaction": 276394,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeTermOfLeaseMember",
    "propertyplantandequipmentgross": 3277000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7091000,
    "accruedclinicaltrialcostcurrent": 853000,
    "employeerelatedliabilitiescurrent": 295000,
    "accruedprofessionalfeescurrent": 58000,
    "otheraccruedliabilitiescurrent": 36000,
    "cashandcashequivalentsfairvaluedisclosure": 1337000,
    "assetsfairvaluedisclosure": 1337000,
    "warrantliabilities": 2275000,
    "liabilitiesfairvaluedisclosure": 2351000,
    "warrantsissued": 4325000,
    "warrantsandrightsoutstandingmeasurementinput": 3.81,
    "lesseeoperatingleasediscountrate": 0.07,
    "lesseeoperatingleaseassumptionsandjudgmentsdiscountratedescription": "The leases do not provide an implicit rate so in determining the present value of lease payments, the Company utilized its incremental borrowing rate for the applicable lease, which was 7.0%.",
    "operatingleaseliability": 300000,
    "operatingleasesfutureminimumpaymentsdue": 150482,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4718,
    "operatingleasepayments": 181000,
    "operatingleaseexpense": 181000,
    "interestexpensedebt": 1441,
    "commonstockcapitalsharesreservedforfutureissuance": 14323,
    "percentageofvotingpowerofallclassesofstocktobeownedbyoptioneetodetermineexerciseprice": 0.1,
    "exercisepriceaspercentageoffairvalueofcommonstockongrantdateifoptioneeownsstockrepresentingmorethan10percentofvotingpowerofallclassesofstock": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "percentageofincreaseincommonstockcapitalsharesreservedforfutureissuance": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 58.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 511673,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 448511,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsmaximumcontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 14323,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 6535,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 309,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 188,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 6682,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 446.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 84.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 302.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 3129,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 785.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm1": "P9Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.039,
    "allocatedsharebasedcompensationexpense": 184000,
    "valuationallowancedeferredtaxassetchangeinamount": 6600000,
    "operatinglosscarryforwards": 298600000,
    "operatinglosscarryforwardsexpirationdate": "2034-12-31",
    "taxcreditcarryforwardamount": 23800000,
    "taxcreditcarryforwardexpirationdate": "2021-12-31",
    "incometaxexaminationdescription": "from January 1, 2020 to December 31, 2023",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.057,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.007,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.331,
    "deferredtaxassetsoperatinglosscarryforwards": 78525000,
    "deferredtaxassetsinprocessresearchanddevelopment": 23809000,
    "deferredtaxassetsdepreciationandamortization": 6529000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreserves": 46000,
    "deferredtaxassetsother": 607000,
    "deferredtaxassetsgross": 109516000,
    "deferredtaxassetsvaluationallowance": 109516000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 891,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  },
  {
    "date": "2022-12-30",
    "symbol": "VCNX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VCNX",
    "entityregistrantname": "Vaccinex, Inc.",
    "entitycentralindexkey": 1205922,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38624",
    "entitytaxidentificationnumber": "16-1603202",
    "entityaddressaddressline1": "1895 Mount Hope Avenue",
    "entityaddresscityortown": "Rochester",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 14620,
    "cityareacode": 585,
    "localphonenumber": "271-2700",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "Nasdaq",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Rochester, New York",
    "cashandcashequivalentsatcarryingvalue": 6391000,
    "accountsreceivablenetcurrent": 175000,
    "prepaidexpenseandotherassetscurrent": 912000,
    "assetscurrent": 7478000,
    "propertyplantandequipmentnet": 189000,
    "operatingleaserightofuseasset": 300000,
    "assets": 7977000,
    "accountspayablecurrent": 1518000,
    "accruedliabilitiescurrent": 781000,
    "longtermdebtcurrent": 74000,
    "operatingleaseliabilitycurrent": 164000,
    "liabilitiescurrent": 2537000,
    "longtermdebtnoncurrent": 101000,
    "operatingleaseliabilitynoncurrent": 146000,
    "liabilities": 2784000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 324875000,
    "treasurystockvalue": 11000,
    "retainedearningsaccumulateddeficit": -319676000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 5193000,
    "liabilitiesandstockholdersequity": 7977000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "treasurystockcommonshares": 852,
    "revenuefromcontractwithcustomerexcludingassessedtax": 275000,
    "researchanddevelopmentexpense": 13979000,
    "generalandadministrativeexpense": 6202000,
    "costsandexpenses": 20181000,
    "operatingincomeloss": -19906000,
    "interestexpense": 2000,
    "othernonoperatingincomeexpense": 93000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -19815000,
    "comprehensiveincomenetoftax": -19815000,
    "earningspersharebasic": -0.47,
    "earningspersharediluted": -0.47,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": 852,
    "stockissuedduringperiodvaluenewissues": 17051000,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 545000,
    "profitloss": -19815000,
    "depreciation": 207000,
    "sharebasedcompensation": 545000,
    "increasedecreaseinaccountsreceivable": 175000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 94000,
    "increasedecreaseinaccountspayable": 457000,
    "increasedecreaseinaccruedliabilities": -199000,
    "netcashprovidedbyusedinoperatingactivities": -19074000,
    "paymentstoacquirepropertyplantandequipment": 99000,
    "netcashprovidedbyusedininvestingactivities": -99000,
    "proceedsfromissuanceofcommonstock": 3560000,
    "repaymentsoflongtermdebt": 75000,
    "proceedsfromissuanceofprivateplacement": 13500000,
    "netcashprovidedbyusedinfinancingactivities": 16975000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2198000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 6391000,
    "saleofstocknumberofsharesissuedintransaction": "null",
    "saleofstockpricepershare": 1.12,
    "saleofstockconsiderationreceivedpertransaction": 3600000,
    "grantrevenue": 175000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or remaining lease term",
    "propertyplantandequipmentgross": 7445000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7256000,
    "accruedclinicaltrialcostcurrent": 335000,
    "employeerelatedliabilitiescurrent": 308000,
    "accruedprofessionalfeescurrent": 127000,
    "otheraccruedliabilitiescurrent": 11000,
    "cashandcashequivalentsfairvaluedisclosure": 3975000,
    "assetsfairvaluedisclosure": 3975000,
    "termsoflicenseagreementupontermination": "the Company will issue to VX3 or its designees the number of shares of the Company’s common stock equal to the lesser of (1) the aggregate of all payments made to VX3 by its partners divided by $18.20 and (2) the then fair market value of VX3 divided by the then fair market value of one share of the Company’s common stock",
    "costmaintenance": 50000,
    "businessexitcosts1": 25500000,
    "royaltypaymentspercentofnetsales": 0.01,
    "lesseeoperatingleasediscountrate": 0.07,
    "lesseeoperatingleaseassumptionsandjudgmentsdiscountratedescription": "The leases do not provide an implicit rate so in determining the present value of lease payments, the Company utilized its incremental borrowing rate for the applicable lease, which was 7.0%.",
    "operatingleaseliability": 309850,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 331060,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 21210,
    "operatingleasepayments": 175000,
    "operatingleasesrentexpensenet": 175000,
    "commonstockcapitalsharesreservedforfutureissuance": 425000,
    "percentageofvotingpowerofallclassesofstocktobeownedbyoptioneetodetermineexerciseprice": 0.1,
    "exercisepriceaspercentageoffairvalueofcommonstockongrantdateifoptioneeownsstockrepresentingmorethan10percentofvotingpowerofallclassesofstock": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "percentageofincreaseincommonstockcapitalsharesreservedforfutureissuance": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "eight years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 615378,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 4000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 561198,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsmaximumcontractualterm": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 642478,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 12948,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm1": 9.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024,
    "allocatedsharebasedcompensationexpense": 545000,
    "valuationallowancedeferredtaxassetchangeinamount": 6300000,
    "operatinglosscarryforwards": 298900000,
    "operatinglosscarryforwardsexpirationdate": "December 31, 2024",
    "taxcreditcarryforwardamount": 22700000,
    "taxcreditcarryforwardexpirationdate": "December 31, 2021",
    "incometaxexaminationdescription": "from January 1, 2019 to December 31, 2022",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.051,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.052000000000000005,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": -0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.31,
    "deferredtaxassetsoperatinglosscarryforwards": 75795000,
    "deferredtaxassetsinprocessresearchanddevelopment": 22721000,
    "deferredtaxassetsdepreciationandamortization": 3627000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreserves": 84000,
    "deferredtaxassetsother": 510000,
    "deferredtaxassetsgross": 102737000,
    "deferredtaxassetsvaluationallowance": 102737000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  },
  {
    "date": "2021-12-30",
    "symbol": "VCNX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VCNX",
    "entityregistrantname": "Vaccinex, Inc.",
    "entitycentralindexkey": 1205922,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38624",
    "entitytaxidentificationnumber": "16-1603202",
    "entityaddressaddressline1": "1895 Mount Hope Avenue",
    "entityaddresscityortown": "Rochester",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 14620,
    "cityareacode": 585,
    "localphonenumber": "271-2700",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "Nasdaq",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "auditorfirmid": 34,
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Rochester, New York",
    "cashandcashequivalentsatcarryingvalue": 8589000,
    "prepaidexpenseandotherassetscurrent": 816000,
    "assetscurrent": 9405000,
    "propertyplantandequipmentnet": 297000,
    "operatingleaserightofuseasset": 300000,
    "assets": 9843000,
    "accountspayablecurrent": 1061000,
    "accruedliabilitiescurrent": 980000,
    "longtermdebtcurrent": 74000,
    "operatingleaseliability": 300000,
    "liabilitiescurrent": 2256000,
    "longtermdebtnoncurrent": 175000,
    "liabilities": 2431000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 307281000,
    "treasurystockvalue": 11000,
    "retainedearningsaccumulateddeficit": -299861000,
    "stockholdersequity": 7412000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 7412000,
    "liabilitiesandstockholdersequity": 9843000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "treasurystockcommonshares": 852,
    "revenuefromcontractwithcustomerexcludingassessedtax": 850000,
    "researchanddevelopmentexpense": 17160000,
    "generalandadministrativeexpense": 6230000,
    "costsandexpenses": 23390000,
    "operatingincomeloss": -22490000,
    "interestexpense": 809000,
    "gainlossonforgivenessofpaycheckprotectionprogramloan": 876000,
    "othernonoperatingincomeexpense": 43000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -22380000,
    "profitloss": -22380000,
    "netincomeloss": -22380000,
    "comprehensiveincomenetoftax": -22380000,
    "earningspersharebasicanddiluted": -0.78,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": 852,
    "stockissuedduringperiodvaluenewissues": 32848000,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 541000,
    "stockissuedduringperiodvalueconversionofunits": -23963000,
    "stockissuedduringperiodsharesconversionofunits": "null",
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 985000,
    "stockissuedduringperiodsharessharebasedcompensation": 9979,
    "depreciation": 169000,
    "interestexpensedebt": 358105,
    "sharebasedcompensation": 541000,
    "increasedecreaseinaccountsreceivable": -157000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 302000,
    "increasedecreaseinaccountspayable": -2108000,
    "increasedecreaseinaccruedliabilities": -957000,
    "netcashprovidedbyusedinoperatingactivities": -25298000,
    "paymentstoacquirepropertyplantandequipment": 32000,
    "netcashprovidedbyusedininvestingactivities": -32000,
    "proceedsfromissuanceofcommonstock": 32848000,
    "redemptionofconvertibledebt": 8531000,
    "paymentsofstockissuancecosts": 985000,
    "repaymentsoflongtermdebt": 9000,
    "netcashprovidedbyusedinfinancingactivities": 23323000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2007000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 8589000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 19000,
    "forgivenessofpaycheckprotectionprogramloan": 876000,
    "saleofstockconsiderationreceivedontransaction": 31900000,
    "saleofstocknumberofsharesissuedintransaction": 47319,
    "stockpurchaseprogramnumberofsharesagreetopurchase": 5000000,
    "saleofstockconsiderationreceivedpertransaction": 300000,
    "numberofoperatingsegments": 1,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 300000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or remaining lease term",
    "propertyplantandequipmentgross": 7346000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7049000,
    "accruedclinicaltrialcostcurrent": 468000,
    "employeerelatedliabilitiescurrent": 409000,
    "accruedprofessionalfeescurrent": 74000,
    "otheraccruedliabilitiescurrent": 29000,
    "cashandcashequivalentsfairvaluedisclosure": 426000,
    "assetsfairvaluedisclosure": 426000,
    "termsoflicenseagreementupontermination": "the Company will issue to VX3 or its designees the number of shares of the Company’s common stock equal to the lesser of (1) the aggregate of all payments made to VX3 by its partners divided by $18.20 and (2) the then fair market value of VX3 divided by the then fair market value of one share of the Company’s common stock",
    "partnerscapitalaccountunitsconverted": "null",
    "costmaintenance": 50000,
    "businessexitcosts1": 25500000,
    "royaltypaymentspercentofnetsales": 0.01,
    "lesseeoperatingleasediscountrate": 0.07,
    "lesseeoperatingleaseassumptionsandjudgmentsdiscountratedescription": "The leases do not provide an implicit rate so in determining the present value of lease payments, the Company utilized its incremental borrowing rate for the applicable lease, which was 7.0%.",
    "operatingleasesfutureminimumpaymentsdueintwoyears": 145110,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4549,
    "operatingleasepayments": 174000,
    "operatingleasesrentexpensenet": 174000,
    "interestpayablecurrentandnoncurrent": 4000,
    "sharessubjecttomandatoryredemptionsettlementtermsamount": 416897,
    "commonstockcapitalsharesreservedforfutureissuance": 425000,
    "percentageofvotingpowerofallclassesofstocktobeownedbyoptioneetodetermineexerciseprice": 0.1,
    "exercisepriceaspercentageoffairvalueofcommonstockongrantdateifoptioneeownsstockrepresentingmorethan10percentofvotingpowerofallclassesofstock": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "percentageofincreaseincommonstockcapitalsharesreservedforfutureissuance": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "eight years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 346944,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 322067,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 621996,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsmaximumcontractualterm": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 25249,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 671042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.006999999999999999,
    "allocatedsharebasedcompensationexpense": 541000,
    "valuationallowancedeferredtaxassetchangeinamount": 7200000,
    "operatinglosscarryforwards": 291300000,
    "operatinglosscarryforwardsexpirationdate": "December 31, 2024",
    "taxcreditcarryforwardamount": 21700000,
    "taxcreditcarryforwardexpirationdate": "December 31, 2021",
    "incometaxexaminationdescription": "from January 1, 2018 to December 31, 2021",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.053,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.055,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.324,
    "deferredtaxassetsoperatinglosscarryforwards": 73802000,
    "deferredtaxassetsinprocessresearchanddevelopment": 21717000,
    "deferredtaxassetsdepreciationandamortization": 394000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreserves": 96000,
    "deferredtaxassetsother": 449000,
    "deferredtaxassetsgross": 96458000,
    "deferredtaxassetsvaluationallowance": 96458000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 612876,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  },
  {
    "date": "2020-12-30",
    "symbol": "VCNX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VCNX",
    "entityregistrantname": "Vaccinex, Inc.",
    "entitycentralindexkey": 1205922,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-38624",
    "entitytaxidentificationnumber": "16-1603202",
    "entityaddressaddressline1": "1895 Mount Hope Avenue",
    "entityaddresscityortown": "Rochester",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 14620,
    "cityareacode": 585,
    "localphonenumber": "271-2700",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "cashandcashequivalentsatcarryingvalue": 10596000,
    "accountsreceivablenetcurrent": 157000,
    "prepaidexpenseandotherassetscurrent": 533000,
    "assetscurrent": 11286000,
    "propertyplantandequipmentnet": 416000,
    "assets": 11702000,
    "accountspayablecurrent": 3169000,
    "accruedliabilitiescurrent": 1937000,
    "convertibledebt": 8074000,
    "liabilitiescurrent": 13180000,
    "longtermdebtnoncurrent": 1134000,
    "liabilities": 14314000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 250914000,
    "treasurystockvalue": 11000,
    "retainedearningsaccumulateddeficit": -277481000,
    "stockholdersequity": -26575000,
    "minorityinterest": 23963000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 23963000,
    "liabilitiesandstockholdersequity": 11702000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 22388027,
    "commonstocksharesoutstanding": 22387175,
    "treasurystockcommonshares": 852,
    "revenuefromcontractwithcustomerexcludingassessedtax": 50000,
    "grantrevenue": 575000,
    "costofrevenue": 2000,
    "researchanddevelopmentexpense": 21549000,
    "generalandadministrativeexpense": 7405000,
    "costsandexpenses": 28956000,
    "operatingincomeloss": -28331000,
    "interestexpense": 489000,
    "othernonoperatingincomeexpense": -31000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -28851000,
    "profitloss": -28851000,
    "netincomeloss": -28851000,
    "comprehensiveincomenetoftax": -28851000,
    "earningspersharebasicanddiluted": -1.54,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 18786768,
    "sharesoutstanding": 852,
    "stockissuedduringperiodvaluenewissues": 28475000,
    "stockissuedduringperiodsharesnewissues": 7450004,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 713000,
    "stockissuedduringperiodsharesconversionofunits": 26241,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 732000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionshares": 20000,
    "stockissuedduringperiodvaluestockoptionsexercised": 19000,
    "stockissuedduringperiodsharesstockoptionsexercised": 3783,
    "depreciation": 307000,
    "interestexpensedebt": 554303,
    "sharebasedcompensation": 732000,
    "increasedecreaseinderivativeliabilities": -65000,
    "increasedecreaseinaccountsreceivable": -741000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 197000,
    "increasedecreaseinaccountspayable": 122000,
    "increasedecreaseinaccruedliabilities": -1733000,
    "netcashprovidedbyusedinoperatingactivities": -28647000,
    "paymentstoacquirepropertyplantandequipment": 290000,
    "netcashprovidedbyusedininvestingactivities": -290000,
    "proceedsfromissuanceofprivateplacement": 11475000,
    "proceedsfromissuanceofcommonstock": 17000000,
    "proceedsfromissuanceofconvertibledebtnetofdiscount": 8000000,
    "redemptionofconvertibledebt": 108000,
    "paymentsofdebtissuancecosts": 50000,
    "proceedsfromissuanceoflongtermdebt": 1134000,
    "paymentsofstockissuancecosts": 713000,
    "proceedsfromstockoptionsexercised": 19000,
    "netcashprovidedbyusedinfinancingactivities": 36757000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 7820000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 10596000,
    "saleofstockconsiderationreceivedontransaction": 37600000,
    "stockpurchaseprogramnumberofsharesagreetopurchase": 5000000,
    "saleofstocknumberofsharesissuedintransaction": 47319,
    "saleofstockconsiderationreceivedpertransaction": 300000,
    "deferredofferingcosts": 713000,
    "numberofoperatingsegments": 1,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 3000000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or remaining lease term",
    "propertyplantandequipmentgross": 7296000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6880000,
    "accruedclinicaltrialcostcurrent": 987000,
    "employeerelatedliabilitiescurrent": 428000,
    "accruedprofessionalfeescurrent": 225000,
    "accruedinterestcurrent": 250000,
    "otheraccruedliabilitiescurrent": 47000,
    "cashandcashequivalentsfairvaluedisclosure": 1026000,
    "assetsfairvaluedisclosure": 1026000,
    "termsoflicenseagreementupontermination": "the Company will issue to VX3 or its designees the number of shares of the Company’s common stock equal to the lesser of (1) the aggregate of all payments made to VX3 by its partners divided by $18.20 and (2) the then fair market value of VX3 divided by the then fair market value of one share of the Company’s common stock.",
    "variableinterestentityownershippercentage": 0.9,
    "costmaintenance": 50000000,
    "businessexitcosts1": 25500000,
    "royaltypaymentspercentofnetsales": 0.01,
    "operatingleasesfutureminimumpaymentsduecurrent": 174132,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 145110000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 145110000,
    "operatingleasesrentexpensenet": 169000,
    "interestpayablecurrentandnoncurrent": 7400,
    "debtinstrumentcarryingamount": 8531000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 458000,
    "longtermdebt": 8074000,
    "sharessubjecttomandatoryredemptionsettlementtermsamount": 7610,
    "derivativegainlossonderivativenet": 65000,
    "commonstockcapitalsharesreservedforfutureissuance": 425000,
    "partnerscapitalaccountunitsconverted": 26241,
    "percentageofvotingpowerofallclassesofstocktobeownedbyoptioneetodetermineexerciseprice": 0.1,
    "exercisepriceaspercentageoffairvalueofcommonstockongrantdateifoptioneeownsstockrepresentingmorethan10percentofvotingpowerofallclassesofstock": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "percentageofincreaseincommonstockcapitalsharesreservedforfutureissuance": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 330845,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 732408,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 628036,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsmaximumcontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 832868,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 73925,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 577006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.83,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.45,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 3000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.009,
    "allocatedsharebasedcompensationexpense": 732000,
    "valuationallowancedeferredtaxassetchangeinamount": 9800000,
    "operatinglosscarryforwards": 268100000,
    "operatinglosscarryforwardsexpirationdate": "2034-12-31",
    "taxcreditcarryforwardamount": 20500000,
    "taxcreditcarryforwardexpirationdate": "2021-12-31",
    "incometaxexaminationdescription": "from January 1, 2017 to December 31, 2020",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.051,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.082,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": -0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.341,
    "deferredtaxassetsoperatinglosscarryforwards": 67737000,
    "deferredtaxassetsinprocessresearchanddevelopment": 20513000,
    "deferredtaxassetsdepreciationandamortization": 424000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreserves": 229000,
    "deferredtaxassetsother": 381000,
    "deferredtaxassetsgross": 89284000,
    "deferredtaxassetsvaluationallowance": 89284000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1318797,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  },
  {
    "date": "2019-12-30",
    "symbol": "VCNX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "VCNX",
    "entityregistrantname": "Vaccinex, Inc.",
    "entitycentralindexkey": 1205922,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-38624",
    "entitytaxidentificationnumber": "16-1603202",
    "entityaddressaddressline1": "1895 Mount Hope Avenue",
    "entityaddresscityortown": "Rochester",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 14620,
    "cityareacode": 585,
    "localphonenumber": "271-2700",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "cashandcashequivalentsatcarryingvalue": 2776000,
    "accountsreceivablenetcurrent": 898000,
    "prepaidexpenseandotherassetscurrent": 336000,
    "assetscurrent": 4010000,
    "propertyplantandequipmentnet": 594000,
    "assets": 4604000,
    "accountspayablecurrent": 3208000,
    "accruedliabilitiescurrent": 3670000,
    "liabilities": 6878000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 222403000,
    "treasurystockvalue": 11000,
    "retainedearningsaccumulateddeficit": -248630000,
    "stockholdersequity": -26237000,
    "minorityinterest": 23963000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 23963000,
    "liabilitiesandstockholdersequity": 4604000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 14887999,
    "commonstocksharesoutstanding": 14887147,
    "treasurystockcommonshares": 852,
    "revenuefromcontractwithcustomerexcludingassessedtax": 100000,
    "costofrevenue": 199000,
    "researchanddevelopmentexpense": 25670000,
    "generalandadministrativeexpense": 6669000,
    "costsandexpenses": 32538000,
    "operatingincomeloss": -32015000,
    "othernonoperatingincomeexpense": 152000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -31863000,
    "profitloss": -31863000,
    "netincomeloss": -31863000,
    "comprehensiveincomenetoftax": -31863000,
    "earningspersharebasicanddiluted": -2.47,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 12880746,
    "sharesoutstanding": 852,
    "stockissuedduringperiodvaluenewissues": 13800000,
    "stockissuedduringperiodsharesnewissues": 3382332,
    "stockissuedduringperiodsharesconversionofunits": 29066,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 447000,
    "depreciation": 249000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 44000,
    "sharebasedcompensation": 447000,
    "increasedecreaseinaccountsreceivable": 260000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -725000,
    "increasedecreaseinaccountspayable": 725000,
    "increasedecreaseinaccruedliabilities": -694000,
    "netcashprovidedbyusedinoperatingactivities": -30715000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 14151000,
    "paymentstoacquirepropertyplantandequipment": 78000,
    "netcashprovidedbyusedininvestingactivities": 14073000,
    "proceedsfromissuanceofprivateplacement": 13800000,
    "netcashprovidedbyusedinfinancingactivities": 13800000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2842000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 2776000,
    "capitalexpendituresincurredbutnotyetpaid": 161000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or remaining lease term",
    "propertyplantandequipmentgross": 7167000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6573000,
    "depreciationdepletionandamortization": 249000,
    "accruedclinicaltrialcostcurrent": 3252000,
    "employeerelatedliabilitiescurrent": 79000,
    "accruedprofessionalfeescurrent": 262000,
    "otheraccruedliabilitiescurrent": 77000,
    "cashandcashequivalentsfairvaluedisclosure": 1464000,
    "assetsfairvaluedisclosure": 1464000,
    "termsoflicenseagreementupontermination": "the Company will issue to VX3 or its designees the number of shares of the Company’s common stock equal to the lesser of (1) the aggregate of all payments made to VX3 by its partners divided by $18.20 and (2) the then fair market value of VX3 divided by the then fair market value of one share of the Company’s common stock.",
    "variableinterestentityownershippercentage": 0.9,
    "proceedsfromcollaborators": 123276,
    "businessexitcosts1": 25500000,
    "royaltypaymentspercentofnetsales": 0.01,
    "operatingleasemonthlyrentalpayments": 14000,
    "operatingleasesfutureminimumpaymentsduecurrent": 140000,
    "operatingleasesrentexpensenet": 168000,
    "commonstockcapitalsharesreservedforfutureissuance": 425000,
    "percentageofvotingpowerofallclassesofstocktobeownedbyoptioneetodetermineexerciseprice": 0.1,
    "exercisepriceaspercentageoffairvalueofcommonstockongrantdateifoptioneeownsstockrepresentingmorethan10percentofvotingpowerofallclassesofstock": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "percentageofincreaseincommonstockcapitalsharesreservedforfutureissuance": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 203936,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 161613,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 627129,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsmaximumcontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 579731,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 29888,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 375479,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.02,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 9.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.025,
    "allocatedsharebasedcompensationexpense": 447000,
    "valuationallowancedeferredtaxassetchangeinamount": 11800000,
    "operatinglosscarryforwards": 240300000,
    "operatinglosscarryforwardsexpirationdate": "2034-12-31",
    "taxcreditcarryforwardamount": 18200000,
    "taxcreditcarryforwardexpirationdate": "2021-12-31",
    "incometaxexaminationdescription": "from January 1, 2016 to December 31, 2019",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.051,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.109,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.371,
    "deferredtaxassetsoperatinglosscarryforwards": 60467000,
    "deferredtaxassetsinprocessresearchanddevelopment": 18161000,
    "deferredtaxassetsdepreciationandamortization": 439000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreserves": 168000,
    "deferredtaxassetsother": 274000,
    "deferredtaxassetsgross": 79509000,
    "deferredtaxassetsvaluationallowance": 79509000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1318797,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  }
]